| Effect of oral naltrexone on pruritus in cholestatic patients F Mansour-Ghanaei, A Taheri, H Froutan, H Ghofrani, M Nasiri-Toosi, ... World journal of gastroenterology: WJG 12 (7), 1125, 2006 | 114 | 2006 |
| A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study. S Rahimpour, M Nasiri-Toosi, H Khalili, NE Daryani, MK Nouri Taromlou, ... Journal of Gastrointestinal & Liver Diseases 25 (4), 2016 | 96 | 2016 |
| Disturbances of parathyroid hormone–vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study A Miroliaee, M Nasiri-Toosi, O Khalilzadeh, A Esteghamati, A Abdollahi, ... Hepatology international 4, 634-640, 2010 | 91 | 2010 |
| Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis A Shah, D Crawford, D Burger, N Martin, M Walker, NJ Talley, C Tallis, ... Seminars in Liver Disease 39 (04), 432-441, 2019 | 64 | 2019 |
| Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time K Samimi-Rad, M Nasiri Toosi, A Masoudi-Nejad, A Najafi, R Rahimnia, ... Archives of virology 157, 1959-1965, 2012 | 53 | 2012 |
| Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini hospital complex in the capital city of Tehran, Iran SF Allameh, S Nemati, R Ghalehtaki, E Mohammadnejad, SM Aghili, ... Archives of Iranian medicine 23 (11), 766-775, 2020 | 41 | 2020 |
| Safety and efficacy of locally manufactured pegylated interferon in hepatitis C patients H JABARI, AA BAYATIAN, AH Sharifi, RH ZAER, E Fakharzadeh, R Asadi, ... ARCHIVES OF IRANIAN MEDICINE 13 (4), 306-312, 2010 | 34 | 2010 |
| Prevalence and severity of depression in chronic viral hepatitis in Iran M Mirabdolhagh Hazaveh, T Dormohammadi Toosi, M Nasiri Toosi, ... Gastroenterology Report 3 (3), 234-237, 2015 | 33 | 2015 |
| Perspective of placenta derived mesenchymal stem cells in acute liver failure M Saleh, M Taher, AA Sohrabpour, AA Vaezi, M Nasiri Toosi, ... Cell & bioscience 10, 1-11, 2020 | 29 | 2020 |
| Liver transplantation status in Iran: a multi-center report on the main transplant indicators and survival rates SA Malek-Hosseini, A Jafarian, S Nikeghbalian, H Poustchi, KB Lankarani, ... Archives of Iranian medicine 21 (7), 275-282, 2018 | 27 | 2018 |
| Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors S Dashti-Khavidaki, H Khalili, M Nasiri-Toosi Expert Review of Clinical Pharmacology 11 (5), 525-529, 2018 | 27 | 2018 |
| Psychosocial status of liver transplant candidates in Iran and its correlation with health-related quality of life and depression and anxiety M Banihashemi, M Hafezi, M Nasiri-Toosi, A Jafarian, MR Abbasi, ... Journal of transplantation 2015, 2015 | 27 | 2015 |
| Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients Z Nasiri-Toosi, S Dashti-Khavidaki, M Nasiri-Toosi, H Khalili, A Jafarian, ... Exp Clin Transplant 10 (6), 586-591, 2012 | 27 | 2012 |
| Seroprevalence of human immunodificiency virus (HIV) and hepatitis C infection in hemophilic patients in Iran A Abdollahi, R Shahsiah, M Nassiri Toosi, M Lak, K Karimi, M Managhchi, ... Iranian Journal of Pathology 3 (3), 119-124, 2008 | 16 | 2008 |
| Risk factors and seroprevalence of hepatitis B and C infections among hemodialysis patients in Tehran TM NASIRI, F Larti, M Rasteh, H FOROUTAN, N Salarieh, ... IRANIAN JOURNAL OF PATHOLOGY (IJP) 2 (4), 181-186, 2007 | 10 | 2007 |
| Antibody‐Mediated Rejection in Adult Liver Transplant Recipients: A Case Series and Literature Review H Baradaran, S Dashti‐Khavidaki, M Taher, M Talebian, M Nasiri‐Toosi, ... The Journal of Clinical Pharmacology 62 (2), 254-271, 2022 | 9 | 2022 |
| Liver-Heart Inter-Relationship in Fatty Liver Disease Based on the Avicenna's Point of View E Khadem, MN Toosi, R Ilkhani Iranian Journal of Public Health 42 (6), 648-649, 2013 | 8 | 2013 |
| Frequency of musculoskeletal complications among the patients receiving solid organ transplantation in a tertiary health-care center S Movassaghi, M Nasiri Toosi, A Bakhshandeh, F Niksolat, Z Khazaeipour, ... Rheumatology international 32, 2363-2366, 2012 | 8 | 2012 |
| Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions S Ravi, M Nasiri-Toosi, I Karimzadeh, H Khalili, M Ahadi-Barzoki, ... Expert opinion on drug safety 13 (3), 277-286, 2014 | 7 | 2014 |
| Management of patients with liver transplant and chronic liver diseases during COVID-19 pandemic: a brief review M Taher, A Miroliaee, NE Daryani, FA Avanaki, N Aletaha, M Nasiri-Toosi, ... Archives of Iranian Medicine 23 (10), 713-717, 2020 | 5 | 2020 |
